Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1994 1
1995 1
1998 1
2000 1
2001 1
2003 1
2006 1
2007 3
2010 3
2011 5
2012 5
2013 5
2014 3
2015 6
2016 7
2017 11
2018 12
2019 12
2020 22
2021 37
2022 33
2023 27
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

189 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for june lian
Search for Junhe Lian instead (3 results)
Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial.
Lv J, Wong MG, Hladunewich MA, Jha V, Hooi LS, Monaghan H, Zhao M, Barbour S, Jardine MJ, Reich HN, Cattran D, Glassock R, Levin A, Wheeler DC, Woodward M, Billot L, Stepien S, Rogers K, Chan TM, Liu ZH, Johnson DW, Cass A, Feehally J, Floege J, Remuzzi G, Wu Y, Agarwal R, Zhang H, Perkovic V; TESTING Study Group. Lv J, et al. JAMA. 2022 May 17;327(19):1888-1898. doi: 10.1001/jama.2022.5368. JAMA. 2022. PMID: 35579642 Free PMC article. Clinical Trial.
DESIGN, SETTING, AND PARTICIPANTS: An international, multicenter, double-blind, randomized clinical trial that enrolled 503 participants with IgA nephropathy, proteinuria greater than or equal to 1 g per day, and estimated glomerular filtration rate (eGFR) of 20 to 120 mL/min/1.7 …
DESIGN, SETTING, AND PARTICIPANTS: An international, multicenter, double-blind, randomized clinical trial that enrolled 503 participants wit …
Retraction.
[No authors listed] [No authors listed] J Cell Physiol. 2022 Apr;237(4):2300. doi: 10.1002/jcp.30675. Epub 2022 Mar 7. J Cell Physiol. 2022. PMID: 35253901
Retraction: "Long noncoding RNA BCAR4 promotes glioma cell proliferation via EGFR/PI3K/AKT signaling pathway" by Lian Wei, Zhao Yi, Kongyan Guo, and Xu Long, J Cell Physiol. 2019; 23608-23617. The above article, published online on 7 June 2019 in Wiley Online Librar …
Retraction: "Long noncoding RNA BCAR4 promotes glioma cell proliferation via EGFR/PI3K/AKT signaling pathway" by Lian Wei, Zhao Yi, K …
Retraction.
[No authors listed] [No authors listed] J Cell Biochem. 2021 Nov;122 Suppl 1:S109. doi: 10.1002/jcb.30089. Epub 2021 Jul 19. J Cell Biochem. 2021. PMID: 34288061
Retraction: "TPX2 gene silencing inhibits cell proliferation and promotes apoptosis through negative regulation of AKT signaling pathway in ovarian cancer," by Yuan Tian, Lian-Lian Liu, Dong-Mei Guo, Yan Wang, Wen-Hui Zha, Yang Li, Fu-Ju Wu, J Cell Biochem. 2018; 75 …
Retraction: "TPX2 gene silencing inhibits cell proliferation and promotes apoptosis through negative regulation of AKT signaling pathway in …
IL-7 and CCL19-secreting CAR-T cell therapy for tumors with positive glypican-3 or mesothelin.
Pang N, Shi J, Qin L, Chen A, Tang Y, Yang H, Huang Y, Wu Q, Li X, He B, Li T, Liang B, Zhang J, Cao B, Liu M, Feng Y, Ye X, Chen X, Wang L, Tian Y, Li H, Li J, Hu H, He J, Hu Y, Zhi C, Tang Z, Gong Y, Xu F, Xu L, Fan W, Zhao M, Chen D, Lian H, Yang L, Li P, Zhang Z. Pang N, et al. J Hematol Oncol. 2021 Jul 29;14(1):118. doi: 10.1186/s13045-021-01128-9. J Hematol Oncol. 2021. PMID: 34325726 Free PMC article. Clinical Trial.
Our results demonstrated that the incorporation of 7 19 into CAR-T cells significantly enhanced the antitumor activity against human solid tumor. Trial registration: NCT03198546. Registered 26 June 2017, https://clinicaltrials.gov/ct2/show/NCT03198546?term=NCT03198546& …
Our results demonstrated that the incorporation of 7 19 into CAR-T cells significantly enhanced the antitumor activity against human solid t …
Safety and effectiveness of metformin plus lifestyle intervention compared with lifestyle intervention alone in preventing progression to diabetes in a Chinese population with impaired glucose regulation: a multicentre, open-label, randomised controlled trial.
Zhang L, Zhang Y, Shen S, Wang X, Dong L, Li Q, Ren W, Li Y, Bai J, Gong Q, Kuang H, Qi L, Lu Q, Cheng W, Liu Y, Yan S, Wu D, Fang H, Hou F, Wang Y, Yang Z, Lian X, Du J, Sun N, Ji L, Li G; China Diabetes Prevention Program Study Group. Zhang L, et al. Lancet Diabetes Endocrinol. 2023 Aug;11(8):567-577. doi: 10.1016/S2213-8587(23)00132-8. Epub 2023 Jul 3. Lancet Diabetes Endocrinol. 2023. PMID: 37414069 Clinical Trial.
This study is registered with ClinicalTrials.gov, number NCT03441750, and is completed. FINDINGS: Between April, 2017, and June, 2019, 3881 individuals were assessed for eligibility, of which 1678 (43.2%) participants were randomly assigned to either the metformin plus lif …
This study is registered with ClinicalTrials.gov, number NCT03441750, and is completed. FINDINGS: Between April, 2017, and June, 2019 …
Genetic characterization of dilated cardiomyopathy patients undergoing heart transplantation in the Chinese population by whole-exome sequencing.
Lian H, Song S, Chen W, Shi A, Jiang H, Hu S. Lian H, et al. J Transl Med. 2023 Jul 17;21(1):476. doi: 10.1186/s12967-023-04282-5. J Transl Med. 2023. PMID: 37461109 Free PMC article.
METHODS: In total, 208 unrelated DCM patients who underwent HTx at Fuwai Hospital between June 2004 and June 2017 were included in this study. Whole-exome sequencing (WES) was performed for all patients. ...
METHODS: In total, 208 unrelated DCM patients who underwent HTx at Fuwai Hospital between June 2004 and June 2017 were include …
Effect of Huang-Lian Jie-Du Decoction on Glucose and Lipid Metabolism in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.
Hu Z, Yang M, Liu Y, Yang Q, Xie H, Peng S, Gao J, Xie C. Hu Z, et al. Front Pharmacol. 2021 Apr 29;12:648861. doi: 10.3389/fphar.2021.648861. eCollection 2021. Front Pharmacol. 2021. PMID: 33995064 Free PMC article.
Background: Type 2 diabetes mellitus (T2DM) is a heterogeneous disease characterized by persistent hyperglycemia. Huang-Lian Jie-Du decoction (HLJDD) is a traditional Chinese medicine formula which is widely used in treating T2DM in China. ...Objective: this study aims to …
Background: Type 2 diabetes mellitus (T2DM) is a heterogeneous disease characterized by persistent hyperglycemia. Huang-Lian Jie-Du d …
Unraveling the link between hypertension and depression in older adults: a meta-analysis.
Gan Q, Yu R, Lian Z, Yuan Y, Li Y, Zheng L. Gan Q, et al. Front Public Health. 2023 Nov 24;11:1302341. doi: 10.3389/fpubh.2023.1302341. eCollection 2023. Front Public Health. 2023. PMID: 38074728 Free PMC article.
METHODS: Eight electronic databases and two clinical trial registries were searched to identify studies examining the incidence of and risk factors for depression among older adults with hypertension. The databases were searched from inception to June 2023. The included st …
METHODS: Eight electronic databases and two clinical trial registries were searched to identify studies examining the incidence of and risk …
Emergence of ehrlichiosis by a new tick-borne Ehrlichia species in China.
Lu M, Qin XC, Jiang YZ, Guo Q, Jin XJ, Teng ZQ, Sun XR, Yu L, Zhang YF, Wang W, Chen QQ, Liang JR, Wan J, Ren HY, Lv Y, Wang YH, Yi L, Chang HW, Hong DY, Zheng C, Lian XX, Li K, Xu PX, Wen B, Kan B, Xu J, Qin T. Lu M, et al. Int J Infect Dis. 2023 Jun;131:32-39. doi: 10.1016/j.ijid.2023.03.038. Epub 2023 Mar 24. Int J Infect Dis. 2023. PMID: 36967037 Free article.
OBJECTIVES: From March to June 2021, the reported number of clinically diagnosed endemic typhus in Anhui and Hubei provinces of China nearly increased four-fold compared with the monthly average numbers in last 5 years. ...
OBJECTIVES: From March to June 2021, the reported number of clinically diagnosed endemic typhus in Anhui and Hubei provinces of China …
Camrelizumab Plus Apatinib and Temozolomide as First-Line Treatment in Patients With Advanced Acral Melanoma: The CAP 03 Phase 2 Nonrandomized Clinical Trial.
Mao L, Lian B, Li C, Bai X, Zhou L, Cui C, Chi Z, Sheng X, Wang X, Tang B, Yan X, Li S, Kong Y, Dai J, Wei X, Li J, Duan R, Xu H, Wu X, Yang Y, Cheng F, Zhang C, Xia F, Pang Z, Guo J, Si L. Mao L, et al. JAMA Oncol. 2023 Aug 1;9(8):1099-1107. doi: 10.1001/jamaoncol.2023.1363. JAMA Oncol. 2023. PMID: 37261804 Clinical Trial.
DESIGN, SETTING, AND PARTICIPANTS: In this single-arm, single-center, phase 2 nonrandomized clinical trial, patients with treatment-naive unresectable stage III or IV acral melanoma were enrolled at Peking University Cancer Hospital and Institute between June 4, 2020, and …
DESIGN, SETTING, AND PARTICIPANTS: In this single-arm, single-center, phase 2 nonrandomized clinical trial, patients with treatment-naive un …
189 results